First-in-Human Study of the GDF-15 Neutralizing Antibody Visugromab (CTL-002) in Patients With Advanced Cancer (GDFATHER)

University Hospital Basel, Department for Medical Oncology, Basel

Kantonsspital St. Gallen, Clinic for Medical Oncology & Hematology, Sankt Gallen

University Hospital Zurich, Department of Dermatology, Zurich

Hospital Universitario 12 de Octubre, Madrid

START Madrid, Hospital Universitario HM Sanchinarro, Madrid

Clinica Universidad de Navarra, Unidad Central de Ensayos Clinicos, Pamplona

Universitätsklinikum Essen, Westdeutsches Tumorzentrum, Innere Klinik und Poliklinik, Essen

Universitätsklinikum Frankfurt, Medizinische Klinik I, Frankfurt am Main

Universitätsklinikum Würzburg, Comprehensive Cancer Center, Würzburg

Next Oncology, Phase I Unit. IOB - Hospital Quironsalud, Barcelona

Hospital Universitari Vall d'Hebron, Institute of Oncology, Barcelona

ICMDiM, Hospital Clinic, Barcelona

ICO Hospitalet, Hospital Duran i Reynals, Barcelona